Global Single-Use Technology for Biopharmaceuticals Market Growth (Status and Outlook) 2026-2032

October 2026 | 139 pages | ID: G60D81FF25BEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Single-Use Technology for Biopharmaceuticals market size is predicted to grow from US$ 5582 million in 2025 to US$ 10923 million in 2032; it is expected to grow at a CAGR of 10.3% from 2026 to 2032.

Single-Use Technology for Biopharmaceuticals refers to disposable bioprocessing systems, components, and consumables used in the development and manufacturing of biopharmaceutical products. These technologies are designed to be used for a single production batch, process step, or manufacturing campaign and then discarded, replacing traditional stainless-steel systems that require cleaning, sterilization, and validation.

In the biopharmaceutical industry, single-use technology typically includes single-use bioreactors, media and buffer bags, storage bags, mixing systems, tubing assemblies, sterile connectors, filters, sampling systems, sensors, and fill-finish assemblies. These products are widely used in upstream processing, downstream processing, fluid management, formulation, and aseptic transfer for the production of monoclonal antibodies, vaccines, recombinant proteins, cell therapies, gene therapies, mRNA products, and other biologics.

The single-use technology for biopharmaceutical sector is characterized by high gross margins; leading international companies maintain gross margins exceeding 50% thanks to technological barriers and brand advantages.

Single-use technology in biopharmaceuticals is rapidly evolving toward greater intelligence, modularity, and sustainability. Future trends include "smart single-use systems"—integrating sensors and IoT technology—to enable real-time process monitoring and digital control; modular facility designs that shorten construction timelines and enhance production flexibility; and customized single-use solutions tailored for emerging therapies such as mRNA and cell and gene therapies. Regarding sustainability, the industry is shifting from traditional plastics to bio-based, biodegradable materials while simultaneously reducing waste through closed-loop recycling systems.

In terms of raw materials, multi-layer co-extruded films (e.g., polyethylene, EVOH barrier layers), silicone tubing, and thermoplastic elastomers (TPE) remain dominant; however, the supply chain is undergoing profound transformation. There is a heavy reliance on a limited number of European and American suppliers (such as Thermo Fisher, Sartorius, and Merck) for key resins and films, though geopolitical factors and the post-pandemic landscape are driving a diversification of global production capacity. Chinese enterprises are accelerating efforts to achieve import substitution for high-end films and precision connectors. Furthermore, increasingly stringent standards for extractables and leachables (E&L) are pushing raw materials toward higher purity, lower adsorption, and reduced particle shedding, with biocompatibility certifications (e.g., USP Class VI, ISO 10993) becoming essential market entry requirements.

LPI (LP Information)' newest research report, the “Single-Use Technology for Biopharmaceuticals Industry Forecast” looks at past sales and reviews total world Single-Use Technology for Biopharmaceuticals sales in 2025, providing a comprehensive analysis by region and market sector of projected Single-Use Technology for Biopharmaceuticals sales for 2026 through 2032. With Single-Use Technology for Biopharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Single-Use Technology for Biopharmaceuticals industry.

This Insight Report provides a comprehensive analysis of the global Single-Use Technology for Biopharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Single-Use Technology for Biopharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Single-Use Technology for Biopharmaceuticals market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Single-Use Technology for Biopharmaceuticals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Single-Use Technology for Biopharmaceuticals.

This report presents a comprehensive overview, market shares, and growth opportunities of Single-Use Technology for Biopharmaceuticals market by product type, application, key players and key regions and countries.

Segmentation by Type:

  • Single-use Bioreactors
  • Single-use Bags & Containers
  • Filtration Assemblies
  • Tubing & Connectors
  • Others

Segmentation by End User:

  • Biopharmaceutical Companies
  • CDMOs / CMOs
  • Research Institutes
  • Cell & Gene Therapy Companies
  • Vaccine Manufacturers

Segmentation by Scale of Operation:

  • <50 L
  • 50–500 L
  • 500–1,000 L
  • >1,000 L

Segmentation by Application:

  • Monoclonal Antibodies
  • Vaccines
  • Cell & Gene Therapy
  • Recombinant Proteins
  • Others

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Danaher (US)
  • Sartorius (DE)
  • Thermo Fisher Scientific (US)
  • Merck KGaA (DE)
  • Repligen (US)
  • Meissner Filtration Products (US)
  • ABEC (US)
  • Avantor (US)
  • Corning (US)
  • Entegris (US)
  • Saint-Gobain Life Sciences (FR)
  • Watson-Marlow / BioPure (GB)
  • CPC / Colder Products (US)
  • Eppendorf (DE)
  • Getinge / Applikon (SE)
  • PBS Biotech (US)
  • Shanghai Tofflon Science and Technology Co., Ltd. (CN)
  • Shanghai LePure Biotech Co., Ltd. (CN)
  • Shanghai Duoning Biotechnology Co., Ltd. (CN)
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Single-Use Technology for Biopharmaceuticals Market Size (2021-2032)
  2.1.2 Single-Use Technology for Biopharmaceuticals Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Single-Use Technology for Biopharmaceuticals by Country/Region (2021, 2025 & 2032)
2.2 Single-Use Technology for Biopharmaceuticals Segment by Type
  2.2.1 Single-use Bioreactors
  2.2.2 Single-use Bags & Containers
  2.2.3 Filtration Assemblies
  2.2.4 Tubing & Connectors
  2.2.5 Others
  2.2.6 Single-Use Technology for Biopharmaceuticals Market Size by Type
    2.2.6.1 Single-Use Technology for Biopharmaceuticals Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.6.2 Global Single-Use Technology for Biopharmaceuticals Market Size Market Share by Type (2021-2026)
2.3 Single-Use Technology for Biopharmaceuticals Segment by End User
  2.3.1 Biopharmaceutical Companies
  2.3.2 CDMOs / CMOs
  2.3.3 Research Institutes
  2.3.4 Cell & Gene Therapy Companies
  2.3.5 Vaccine Manufacturers
  2.3.6 Single-Use Technology for Biopharmaceuticals Market Size by End User
    2.3.6.1 Single-Use Technology for Biopharmaceuticals Market Size CAGR by End User (2021 VS 2025 VS 2032)
    2.3.6.2 Global Single-Use Technology for Biopharmaceuticals Market Size Market Share by End User (2021-2026)
2.4 Single-Use Technology for Biopharmaceuticals Segment by Scale of Operation
  2.4.1 <50 L
  2.4.2 50–500 L
  2.4.3 500–1,000 L
  2.4.4 >1,000 L
  2.4.5 Single-Use Technology for Biopharmaceuticals Market Size by Scale of Operation
    2.4.5.1 Single-Use Technology for Biopharmaceuticals Market Size CAGR by Scale of Operation (2021 VS 2025 VS 2032)
    2.4.5.2 Global Single-Use Technology for Biopharmaceuticals Market Size Market Share by Scale of Operation (2021-2026)
2.5 Single-Use Technology for Biopharmaceuticals Segment by Application
  2.5.1 Monoclonal Antibodies
  2.5.2 Vaccines
  2.5.3 Cell & Gene Therapy
  2.5.4 Recombinant Proteins
  2.5.5 Others
  2.5.6 Single-Use Technology for Biopharmaceuticals Market Size by Application
    2.5.6.1 Single-Use Technology for Biopharmaceuticals Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.5.6.2 Global Single-Use Technology for Biopharmaceuticals Market Size Market Share by Application (2021-2026)

3 SINGLE-USE TECHNOLOGY FOR BIOPHARMACEUTICALS MARKET SIZE BY PLAYER

3.1 Single-Use Technology for Biopharmaceuticals Market Size Market Share by Player
  3.1.1 Global Single-Use Technology for Biopharmaceuticals Revenue by Player (2021-2026)
  3.1.2 Global Single-Use Technology for Biopharmaceuticals Revenue Market Share by Player (2021-2026)
3.2 Global Single-Use Technology for Biopharmaceuticals Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SINGLE-USE TECHNOLOGY FOR BIOPHARMACEUTICALS BY REGION

4.1 Single-Use Technology for Biopharmaceuticals Market Size by Region (2021-2026)
4.2 Global Single-Use Technology for Biopharmaceuticals Annual Revenue by Country/Region (2021-2026)
4.3 Americas Single-Use Technology for Biopharmaceuticals Market Size Growth (2021-2026)
4.4 APAC Single-Use Technology for Biopharmaceuticals Market Size Growth (2021-2026)
4.5 Europe Single-Use Technology for Biopharmaceuticals Market Size Growth (2021-2026)
4.6 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Single-Use Technology for Biopharmaceuticals Market Size by Country (2021-2026)
5.2 Americas Single-Use Technology for Biopharmaceuticals Market Size by Type (2021-2026)
5.3 Americas Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Single-Use Technology for Biopharmaceuticals Market Size by Region (2021-2026)
6.2 APAC Single-Use Technology for Biopharmaceuticals Market Size by Type (2021-2026)
6.3 APAC Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Single-Use Technology for Biopharmaceuticals Market Size by Country (2021-2026)
7.2 Europe Single-Use Technology for Biopharmaceuticals Market Size by Type (2021-2026)
7.3 Europe Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Single-Use Technology for Biopharmaceuticals by Region (2021-2026)
8.2 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size by Type (2021-2026)
8.3 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SINGLE-USE TECHNOLOGY FOR BIOPHARMACEUTICALS MARKET FORECAST

10.1 Global Single-Use Technology for Biopharmaceuticals Forecast by Region (2027-2032)
  10.1.1 Global Single-Use Technology for Biopharmaceuticals Forecast by Region (2027-2032)
  10.1.2 Americas Single-Use Technology for Biopharmaceuticals Forecast
  10.1.3 APAC Single-Use Technology for Biopharmaceuticals Forecast
  10.1.4 Europe Single-Use Technology for Biopharmaceuticals Forecast
  10.1.5 Middle East & Africa Single-Use Technology for Biopharmaceuticals Forecast
10.2 Americas Single-Use Technology for Biopharmaceuticals Forecast by Country (2027-2032)
  10.2.1 United States Market Single-Use Technology for Biopharmaceuticals Forecast
  10.2.2 Canada Market Single-Use Technology for Biopharmaceuticals Forecast
  10.2.3 Mexico Market Single-Use Technology for Biopharmaceuticals Forecast
  10.2.4 Brazil Market Single-Use Technology for Biopharmaceuticals Forecast
10.3 APAC Single-Use Technology for Biopharmaceuticals Forecast by Region (2027-2032)
  10.3.1 China Single-Use Technology for Biopharmaceuticals Market Forecast
  10.3.2 Japan Market Single-Use Technology for Biopharmaceuticals Forecast
  10.3.3 Korea Market Single-Use Technology for Biopharmaceuticals Forecast
  10.3.4 Southeast Asia Market Single-Use Technology for Biopharmaceuticals Forecast
  10.3.5 India Market Single-Use Technology for Biopharmaceuticals Forecast
  10.3.6 Australia Market Single-Use Technology for Biopharmaceuticals Forecast
10.4 Europe Single-Use Technology for Biopharmaceuticals Forecast by Country (2027-2032)
  10.4.1 Germany Market Single-Use Technology for Biopharmaceuticals Forecast
  10.4.2 France Market Single-Use Technology for Biopharmaceuticals Forecast
  10.4.3 UK Market Single-Use Technology for Biopharmaceuticals Forecast
  10.4.4 Italy Market Single-Use Technology for Biopharmaceuticals Forecast
  10.4.5 Russia Market Single-Use Technology for Biopharmaceuticals Forecast
10.5 Middle East & Africa Single-Use Technology for Biopharmaceuticals Forecast by Region (2027-2032)
  10.5.1 Egypt Market Single-Use Technology for Biopharmaceuticals Forecast
  10.5.2 South Africa Market Single-Use Technology for Biopharmaceuticals Forecast
  10.5.3 Israel Market Single-Use Technology for Biopharmaceuticals Forecast
  10.5.4 Turkey Market Single-Use Technology for Biopharmaceuticals Forecast
10.6 Global Single-Use Technology for Biopharmaceuticals Forecast by Type (2027-2032)
10.7 Global Single-Use Technology for Biopharmaceuticals Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Single-Use Technology for Biopharmaceuticals Forecast

11 KEY PLAYERS ANALYSIS

11.1 Danaher (US)
  11.1.1 Danaher (US) Company Information
  11.1.2 Danaher (US) Single-Use Technology for Biopharmaceuticals Product Offered
  11.1.3 Danaher (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Danaher (US) Main Business Overview
  11.1.5 Danaher (US) Latest Developments
11.2 Sartorius (DE)
  11.2.1 Sartorius (DE) Company Information
  11.2.2 Sartorius (DE) Single-Use Technology for Biopharmaceuticals Product Offered
  11.2.3 Sartorius (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Sartorius (DE) Main Business Overview
  11.2.5 Sartorius (DE) Latest Developments
11.3 Thermo Fisher Scientific (US)
  11.3.1 Thermo Fisher Scientific (US) Company Information
  11.3.2 Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Product Offered
  11.3.3 Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Thermo Fisher Scientific (US) Main Business Overview
  11.3.5 Thermo Fisher Scientific (US) Latest Developments
11.4 Merck KGaA (DE)
  11.4.1 Merck KGaA (DE) Company Information
  11.4.2 Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Product Offered
  11.4.3 Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Merck KGaA (DE) Main Business Overview
  11.4.5 Merck KGaA (DE) Latest Developments
11.5 Repligen (US)
  11.5.1 Repligen (US) Company Information
  11.5.2 Repligen (US) Single-Use Technology for Biopharmaceuticals Product Offered
  11.5.3 Repligen (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Repligen (US) Main Business Overview
  11.5.5 Repligen (US) Latest Developments
11.6 Meissner Filtration Products (US)
  11.6.1 Meissner Filtration Products (US) Company Information
  11.6.2 Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Product Offered
  11.6.3 Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Meissner Filtration Products (US) Main Business Overview
  11.6.5 Meissner Filtration Products (US) Latest Developments
11.7 ABEC (US)
  11.7.1 ABEC (US) Company Information
  11.7.2 ABEC (US) Single-Use Technology for Biopharmaceuticals Product Offered
  11.7.3 ABEC (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 ABEC (US) Main Business Overview
  11.7.5 ABEC (US) Latest Developments
11.8 Avantor (US)
  11.8.1 Avantor (US) Company Information
  11.8.2 Avantor (US) Single-Use Technology for Biopharmaceuticals Product Offered
  11.8.3 Avantor (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Avantor (US) Main Business Overview
  11.8.5 Avantor (US) Latest Developments
11.9 Corning (US)
  11.9.1 Corning (US) Company Information
  11.9.2 Corning (US) Single-Use Technology for Biopharmaceuticals Product Offered
  11.9.3 Corning (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Corning (US) Main Business Overview
  11.9.5 Corning (US) Latest Developments
11.10 Entegris (US)
  11.10.1 Entegris (US) Company Information
  11.10.2 Entegris (US) Single-Use Technology for Biopharmaceuticals Product Offered
  11.10.3 Entegris (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Entegris (US) Main Business Overview
  11.10.5 Entegris (US) Latest Developments
11.11 Saint-Gobain Life Sciences (FR)
  11.11.1 Saint-Gobain Life Sciences (FR) Company Information
  11.11.2 Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Product Offered
  11.11.3 Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Saint-Gobain Life Sciences (FR) Main Business Overview
  11.11.5 Saint-Gobain Life Sciences (FR) Latest Developments
11.12 Watson-Marlow / BioPure (GB)
  11.12.1 Watson-Marlow / BioPure (GB) Company Information
  11.12.2 Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Product Offered
  11.12.3 Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 Watson-Marlow / BioPure (GB) Main Business Overview
  11.12.5 Watson-Marlow / BioPure (GB) Latest Developments
11.13 CPC / Colder Products (US)
  11.13.1 CPC / Colder Products (US) Company Information
  11.13.2 CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Product Offered
  11.13.3 CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 CPC / Colder Products (US) Main Business Overview
  11.13.5 CPC / Colder Products (US) Latest Developments
11.14 Eppendorf (DE)
  11.14.1 Eppendorf (DE) Company Information
  11.14.2 Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Product Offered
  11.14.3 Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 Eppendorf (DE) Main Business Overview
  11.14.5 Eppendorf (DE) Latest Developments
11.15 Getinge / Applikon (SE)
  11.15.1 Getinge / Applikon (SE) Company Information
  11.15.2 Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Product Offered
  11.15.3 Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 Getinge / Applikon (SE) Main Business Overview
  11.15.5 Getinge / Applikon (SE) Latest Developments
11.16 PBS Biotech (US)
  11.16.1 PBS Biotech (US) Company Information
  11.16.2 PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Product Offered
  11.16.3 PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.16.4 PBS Biotech (US) Main Business Overview
  11.16.5 PBS Biotech (US) Latest Developments
11.17 Shanghai Tofflon Science and Technology Co., Ltd. (CN)
  11.17.1 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Company Information
  11.17.2 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product Offered
  11.17.3 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.17.4 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Main Business Overview
  11.17.5 Shanghai Tofflon Science and Technology Co., Ltd. (CN) Latest Developments
11.18 Shanghai LePure Biotech Co., Ltd. (CN)
  11.18.1 Shanghai LePure Biotech Co., Ltd. (CN) Company Information
  11.18.2 Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product Offered
  11.18.3 Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.18.4 Shanghai LePure Biotech Co., Ltd. (CN) Main Business Overview
  11.18.5 Shanghai LePure Biotech Co., Ltd. (CN) Latest Developments
11.19 Shanghai Duoning Biotechnology Co., Ltd. (CN)
  11.19.1 Shanghai Duoning Biotechnology Co., Ltd. (CN) Company Information
  11.19.2 Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product Offered
  11.19.3 Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
  11.19.4 Shanghai Duoning Biotechnology Co., Ltd. (CN) Main Business Overview
  11.19.5 Shanghai Duoning Biotechnology Co., Ltd. (CN) Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Single-Use Technology for Biopharmaceuticals Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Single-Use Technology for Biopharmaceuticals Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single-use Bioreactors
Table 4. Major Players of Single-use Bags & Containers
Table 5. Major Players of Filtration Assemblies
Table 6. Major Players of Tubing & Connectors
Table 7. Major Players of Others
Table 8. Single-Use Technology for Biopharmaceuticals Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Single-Use Technology for Biopharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Single-Use Technology for Biopharmaceuticals Market Size Market Share by Type (2021-2026)
Table 11. Major Players of Biopharmaceutical Companies
Table 12. Major Players of CDMOs / CMOs
Table 13. Major Players of Research Institutes
Table 14. Major Players of Cell & Gene Therapy Companies
Table 15. Major Players of Vaccine Manufacturers
Table 16. Single-Use Technology for Biopharmaceuticals Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global Single-Use Technology for Biopharmaceuticals Market Size by End User (2021-2026) & ($ millions)
Table 18. Global Single-Use Technology for Biopharmaceuticals Market Size Market Share by End User (2021-2026)
Table 19. Major Players of <50 L
Table 20. Major Players of 50–500 L
Table 21. Major Players of 500–1,000 L
Table 22. Major Players of >1,000 L
Table 23. Single-Use Technology for Biopharmaceuticals Market Size CAGR by Scale of Operation (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global Single-Use Technology for Biopharmaceuticals Market Size by Scale of Operation (2021-2026) & ($ millions)
Table 25. Global Single-Use Technology for Biopharmaceuticals Market Size Market Share by Scale of Operation (2021-2026)
Table 26. Single-Use Technology for Biopharmaceuticals Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 27. Global Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 28. Global Single-Use Technology for Biopharmaceuticals Market Size Market Share by Application (2021-2026)
Table 29. Global Single-Use Technology for Biopharmaceuticals Revenue by Player (2021-2026) & ($ millions)
Table 30. Global Single-Use Technology for Biopharmaceuticals Revenue Market Share by Player (2021-2026)
Table 31. Single-Use Technology for Biopharmaceuticals Key Players Head office and Products Offered
Table 32. Single-Use Technology for Biopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Mergers & Acquisitions, Expansion
Table 35. Global Single-Use Technology for Biopharmaceuticals Market Size by Region (2021-2026) & ($ millions)
Table 36. Global Single-Use Technology for Biopharmaceuticals Market Size Market Share by Region (2021-2026)
Table 37. Global Single-Use Technology for Biopharmaceuticals Revenue by Country/Region (2021-2026) & ($ millions)
Table 38. Global Single-Use Technology for Biopharmaceuticals Revenue Market Share by Country/Region (2021-2026)
Table 39. Americas Single-Use Technology for Biopharmaceuticals Market Size by Country (2021-2026) & ($ millions)
Table 40. Americas Single-Use Technology for Biopharmaceuticals Market Size Market Share by Country (2021-2026)
Table 41. Americas Single-Use Technology for Biopharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 42. Americas Single-Use Technology for Biopharmaceuticals Market Size Market Share by Type (2021-2026)
Table 43. Americas Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 44. Americas Single-Use Technology for Biopharmaceuticals Market Size Market Share by Application (2021-2026)
Table 45. APAC Single-Use Technology for Biopharmaceuticals Market Size by Region (2021-2026) & ($ millions)
Table 46. APAC Single-Use Technology for Biopharmaceuticals Market Size Market Share by Region (2021-2026)
Table 47. APAC Single-Use Technology for Biopharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 48. APAC Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 49. Europe Single-Use Technology for Biopharmaceuticals Market Size by Country (2021-2026) & ($ millions)
Table 50. Europe Single-Use Technology for Biopharmaceuticals Market Size Market Share by Country (2021-2026)
Table 51. Europe Single-Use Technology for Biopharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 52. Europe Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 53. Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size by Region (2021-2026) & ($ millions)
Table 54. Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 55. Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 56. Key Market Drivers & Growth Opportunities of Single-Use Technology for Biopharmaceuticals
Table 57. Key Market Challenges & Risks of Single-Use Technology for Biopharmaceuticals
Table 58. Key Industry Trends of Single-Use Technology for Biopharmaceuticals
Table 59. Global Single-Use Technology for Biopharmaceuticals Market Size Forecast by Region (2027-2032) & ($ millions)
Table 60. Global Single-Use Technology for Biopharmaceuticals Market Size Market Share Forecast by Region (2027-2032)
Table 61. Global Single-Use Technology for Biopharmaceuticals Market Size Forecast by Type (2027-2032) & ($ millions)
Table 62. Global Single-Use Technology for Biopharmaceuticals Market Size Forecast by Application (2027-2032) & ($ millions)
Table 63. Danaher (US) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 64. Danaher (US) Single-Use Technology for Biopharmaceuticals Product Offered
Table 65. Danaher (US) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Danaher (US) Main Business
Table 67. Danaher (US) Latest Developments
Table 68. Sartorius (DE) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 69. Sartorius (DE) Single-Use Technology for Biopharmaceuticals Product Offered
Table 70. Sartorius (DE) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Sartorius (DE) Main Business
Table 72. Sartorius (DE) Latest Developments
Table 73. Thermo Fisher Scientific (US) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 74. Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Product Offered
Table 75. Thermo Fisher Scientific (US) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Thermo Fisher Scientific (US) Main Business
Table 77. Thermo Fisher Scientific (US) Latest Developments
Table 78. Merck KGaA (DE) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 79. Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Product Offered
Table 80. Merck KGaA (DE) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Merck KGaA (DE) Main Business
Table 82. Merck KGaA (DE) Latest Developments
Table 83. Repligen (US) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 84. Repligen (US) Single-Use Technology for Biopharmaceuticals Product Offered
Table 85. Repligen (US) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Repligen (US) Main Business
Table 87. Repligen (US) Latest Developments
Table 88. Meissner Filtration Products (US) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 89. Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Product Offered
Table 90. Meissner Filtration Products (US) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Meissner Filtration Products (US) Main Business
Table 92. Meissner Filtration Products (US) Latest Developments
Table 93. ABEC (US) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 94. ABEC (US) Single-Use Technology for Biopharmaceuticals Product Offered
Table 95. ABEC (US) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. ABEC (US) Main Business
Table 97. ABEC (US) Latest Developments
Table 98. Avantor (US) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 99. Avantor (US) Single-Use Technology for Biopharmaceuticals Product Offered
Table 100. Avantor (US) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Avantor (US) Main Business
Table 102. Avantor (US) Latest Developments
Table 103. Corning (US) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 104. Corning (US) Single-Use Technology for Biopharmaceuticals Product Offered
Table 105. Corning (US) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Corning (US) Main Business
Table 107. Corning (US) Latest Developments
Table 108. Entegris (US) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 109. Entegris (US) Single-Use Technology for Biopharmaceuticals Product Offered
Table 110. Entegris (US) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Entegris (US) Main Business
Table 112. Entegris (US) Latest Developments
Table 113. Saint-Gobain Life Sciences (FR) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 114. Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Product Offered
Table 115. Saint-Gobain Life Sciences (FR) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Saint-Gobain Life Sciences (FR) Main Business
Table 117. Saint-Gobain Life Sciences (FR) Latest Developments
Table 118. Watson-Marlow / BioPure (GB) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 119. Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Product Offered
Table 120. Watson-Marlow / BioPure (GB) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Watson-Marlow / BioPure (GB) Main Business
Table 122. Watson-Marlow / BioPure (GB) Latest Developments
Table 123. CPC / Colder Products (US) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 124. CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Product Offered
Table 125. CPC / Colder Products (US) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. CPC / Colder Products (US) Main Business
Table 127. CPC / Colder Products (US) Latest Developments
Table 128. Eppendorf (DE) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 129. Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Product Offered
Table 130. Eppendorf (DE) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Eppendorf (DE) Main Business
Table 132. Eppendorf (DE) Latest Developments
Table 133. Getinge / Applikon (SE) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 134. Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Product Offered
Table 135. Getinge / Applikon (SE) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Getinge / Applikon (SE) Main Business
Table 137. Getinge / Applikon (SE) Latest Developments
Table 138. PBS Biotech (US) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 139. PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Product Offered
Table 140. PBS Biotech (US) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. PBS Biotech (US) Main Business
Table 142. PBS Biotech (US) Latest Developments
Table 143. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 144. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product Offered
Table 145. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Main Business
Table 147. Shanghai Tofflon Science and Technology Co., Ltd. (CN) Latest Developments
Table 148. Shanghai LePure Biotech Co., Ltd. (CN) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 149. Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product Offered
Table 150. Shanghai LePure Biotech Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. Shanghai LePure Biotech Co., Ltd. (CN) Main Business
Table 152. Shanghai LePure Biotech Co., Ltd. (CN) Latest Developments
Table 153. Shanghai Duoning Biotechnology Co., Ltd. (CN) Details, Company Type, Single-Use Technology for Biopharmaceuticals Area Served and Its Competitors
Table 154. Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Product Offered
Table 155. Shanghai Duoning Biotechnology Co., Ltd. (CN) Single-Use Technology for Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. Shanghai Duoning Biotechnology Co., Ltd. (CN) Main Business
Table 157. Shanghai Duoning Biotechnology Co., Ltd. (CN) Latest Developments

LIST OF FIGURES

Figure 1. Single-Use Technology for Biopharmaceuticals Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Single-Use Technology for Biopharmaceuticals Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Single-Use Technology for Biopharmaceuticals Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Single-Use Technology for Biopharmaceuticals Sales Market Share by Country/Region (2025)
Figure 8. Single-Use Technology for Biopharmaceuticals Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Single-Use Technology for Biopharmaceuticals Market Size Market Share by Type in 2025
Figure 10. Global Single-Use Technology for Biopharmaceuticals Market Size Market Share by End User in 2025
Figure 11. Global Single-Use Technology for Biopharmaceuticals Market Size Market Share by Scale of Operation in 2025
Figure 12. Single-Use Technology for Biopharmaceuticals in Monoclonal Antibodies
Figure 13. Global Single-Use Technology for Biopharmaceuticals Market: Monoclonal Antibodies (2021-2026) & ($ millions)
Figure 14. Single-Use Technology for Biopharmaceuticals in Vaccines
Figure 15. Global Single-Use Technology for Biopharmaceuticals Market: Vaccines (2021-2026) & ($ millions)
Figure 16. Single-Use Technology for Biopharmaceuticals in Cell & Gene Therapy
Figure 17. Global Single-Use Technology for Biopharmaceuticals Market: Cell & Gene Therapy (2021-2026) & ($ millions)
Figure 18. Single-Use Technology for Biopharmaceuticals in Recombinant Proteins
Figure 19. Global Single-Use Technology for Biopharmaceuticals Market: Recombinant Proteins (2021-2026) & ($ millions)
Figure 20. Single-Use Technology for Biopharmaceuticals in Others
Figure 21. Global Single-Use Technology for Biopharmaceuticals Market: Others (2021-2026) & ($ millions)
Figure 22. Global Single-Use Technology for Biopharmaceuticals Market Size Market Share by Application in 2025
Figure 23. Global Single-Use Technology for Biopharmaceuticals Revenue Market Share by Player in 2025
Figure 24. Global Single-Use Technology for Biopharmaceuticals Market Size Market Share by Region (2021-2026)
Figure 25. Americas Single-Use Technology for Biopharmaceuticals Market Size 2021-2026 ($ millions)
Figure 26. APAC Single-Use Technology for Biopharmaceuticals Market Size 2021-2026 ($ millions)
Figure 27. Europe Single-Use Technology for Biopharmaceuticals Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size 2021-2026 ($ millions)
Figure 29. Americas Single-Use Technology for Biopharmaceuticals Value Market Share by Country in 2025
Figure 30. United States Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Single-Use Technology for Biopharmaceuticals Market Size Market Share by Region in 2025
Figure 35. APAC Single-Use Technology for Biopharmaceuticals Market Size Market Share by Type (2021-2026)
Figure 36. APAC Single-Use Technology for Biopharmaceuticals Market Size Market Share by Application (2021-2026)
Figure 37. China Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 41. India Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Single-Use Technology for Biopharmaceuticals Market Size Market Share by Country in 2025
Figure 44. Europe Single-Use Technology for Biopharmaceuticals Market Size Market Share by Type (2021-2026)
Figure 45. Europe Single-Use Technology for Biopharmaceuticals Market Size Market Share by Application (2021-2026)
Figure 46. Germany Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 47. France Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Single-Use Technology for Biopharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 60. APAC Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 61. Europe Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 63. United States Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 64. Canada Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 65. Mexico Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 66. Brazil Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 67. China Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 68. Japan Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 69. Korea Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 71. India Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 72. Australia Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 73. Germany Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 74. France Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 75. UK Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 76. Italy Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 77. Russia Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 78. Egypt Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 79. South Africa Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 80. Israel Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 81. Turkey Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)
Figure 82. Global Single-Use Technology for Biopharmaceuticals Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Single-Use Technology for Biopharmaceuticals Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Single-Use Technology for Biopharmaceuticals Market Size 2027-2032 ($ millions)